{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:14:06Z","timestamp":1783995246253,"version":"3.55.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The American Thoracic Society (ATS)\/European Respiratory Society defines a positive bronchodilator response (BDR) by a composite of BDR in either forced expiratory volume in 1 second (FEV1) and\/or forced vital capacity (FVC) greater than or equal to 12% and 200 ml (ATS-BDR). We hypothesized that ATS-BDR components would be differentially associated with important chronic obstructive pulmonary disease (COPD) outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine whether ATS-BDR components are differentially associated with clinical, functional, and radiographic features in COPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included subjects with COPD enrolled in the COPDGene study. In the main analysis, we excluded subjects with self-reported asthma. We categorized BDR into the following: 1) No-BDR, no BDR in either FEV1 or FVC; 2) FEV1-BDR, BDR in FEV1 but no BDR in FVC; 3) FVC-BDR, BDR in FVC but no BDR in FEV1; and 4) Combined-BDR, BDR in both FEV1 and FVC. We constructed multivariable logistic, linear, zero-inflated negative binomial, and Cox hazards models to examine the association of BDR categories with symptoms, computed tomography findings, change in FEV1 over time, respiratory exacerbations, and mortality. We also created models using the ATS BDR definition (ATS-BDR) as the main independent variable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 3,340 COPD subjects included in the analysis, 1,083 (32.43%) had ATS-BDR, 182 (5.45%) had FEV1-BDR, 522 (15.63%) had FVC-BDR, and 379 (11.34%) had Combined-BDR. All BDR categories were associated with FEV1 decline compared with No-BDR. Compared with No-BDR, both ATS-BDR and Combined-BDR were associated with higher functional residual capacity %predicted, greater internal perimeter of 10 mm, and greater 6-minute-walk distance. In contrast to ATS-BDR, Combined-BDR was independently associated with less emphysema (adjusted beta regression coefficient, \u22121.67; 95% confidence interval [CI], \u22122.68 to \u22120.65; P\u2009=\u20090.001), more frequent respiratory exacerbations (incidence rate ratio, 1.25; 95% CI, 1.03\u20131.50; P\u2009=\u20090.02) and severe exacerbations (incidence rate ratio, 1.34; 95% CI, 1.05\u20131.71; P\u2009=\u20090.02), and lower mortality (adjusted hazards ratio, 0.76; 95% CI, 0.58\u20130.99; P\u2009=\u20090.046). Sensitivity analysis that included subjects with self-reported history of asthma showed similar findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>BDR in both FEV1 and FVC indicates a COPD phenotype with asthma-like characteristics, and provides clinically more meaningful information than current definitions of BDR.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.201809-601oc","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T18:44:06Z","timestamp":1553539446000},"page":"826-835","source":"Crossref","is-referenced-by-count":54,"title":["Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-6740","authenticated-orcid":false,"given":"Spyridon","family":"Fortis","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Critical Care and Occupational Medicine, University of Iowa Hospital and Clinics, Iowa City, Iowa"},{"name":"Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1521-7520","authenticated-orcid":false,"given":"Alejandro","family":"Comellas","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Occupational Medicine, University of Iowa Hospital and Clinics, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Make","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1342-4334","authenticated-orcid":false,"given":"Craig P.","family":"Hersh","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"},{"name":"Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Bodduluri","sequence":"additional","affiliation":[{"name":"UAB Lung Imaging Core, Lung Health Center, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Georgopoulos","sequence":"additional","affiliation":[{"name":"Medical School"},{"name":"Department of Pulmonary Medicine, and"},{"name":"Department of Intensive Care Medicine, University Hospital of Heraklion, Medical School, University of Crete, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.","family":"Criner","sequence":"additional","affiliation":[{"name":"Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Dransfield","sequence":"additional","affiliation":[{"name":"UAB Lung Imaging Core, Lung Health Center, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Division of Pulmonary and Critical Care Medicine, Birmingham VA Medical Center, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya P.","family":"Bhatt","sequence":"additional","affiliation":[{"name":"UAB Lung Imaging Core, Lung Health Center, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"2026012203385436800_bib1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur Respir J"},{"key":"2026012203385436800_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1378\/chest.14-0810","article-title":"Point: Is an increase in FEV1 and\/or FVC \u2265 12% of control and \u2265 200 mL the best way to assess positive bronchodilator response? Yes","volume":"146","author":"Pellegrino","year":"2014","journal-title":"Chest"},{"key":"2026012203385436800_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S2213-2600(13)70086-9","article-title":"Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations","volume":"1","author":"Calverley","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026012203385436800_bib4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1378\/chest.14-2413","article-title":"Improved criterion for assessing lung function reversibility","volume":"148","author":"Ward","year":"2015","journal-title":"Chest"},{"key":"2026012203385436800_bib5","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1183\/09031936.00052509","article-title":"Prevalence and clinical correlates of bronchoreversibility in severe emphysema","volume":"35","author":"Han","year":"2010","journal-title":"Eur Respir J"},{"key":"2026012203385436800_bib6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/thorax.58.8.659","article-title":"Bronchodilator reversibility testing in chronic obstructive pulmonary disease","volume":"58","author":"Calverley","year":"2003","journal-title":"Thorax"},{"key":"2026012203385436800_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1465-9921-12-6","article-title":"Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial","volume":"12","author":"Hanania","year":"2011","journal-title":"Respir Res"},{"key":"2026012203385436800_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/thoraxjnl-2011-201458","article-title":"Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary disease","volume":"67","author":"Albert","year":"2012","journal-title":"Thorax"},{"key":"2026012203385436800_bib9","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1183\/09031936.00129607","article-title":"Bronchodilator responsiveness in patients with COPD","volume":"31","author":"Tashkin","year":"2008","journal-title":"Eur Respir J"},{"key":"2026012203385436800_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1081\/JAS-200062992","article-title":"Acute bronchodilator response has limited value in differentiating bronchial asthma from COPD","volume":"42","author":"Chhabra","year":"2005","journal-title":"J Asthma"},{"key":"2026012203385436800_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2147\/COPD.S948","article-title":"Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma","volume":"3","author":"Richter","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203385436800_bib12","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.105.4.1042","article-title":"Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD?","volume":"105","author":"Kesten","year":"1994","journal-title":"Chest"},{"key":"2026012203385436800_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1183\/09031936.93.02060497","article-title":"Diagnostic value of reversibility of chronic airway obstruction to separate asthma from chronic bronchitis: a statistical approach","volume":"2","author":"Meslier","year":"1989","journal-title":"Eur Respir J"},{"key":"2026012203385436800_bib14","doi-asserted-by":"crossref","first-page":"e58932","DOI":"10.1371\/journal.pone.0058932","article-title":"Bronchodilator responsiveness and reported respiratory symptoms in an adult population","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS One"},{"key":"2026012203385436800_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4187\/respcare.02399","article-title":"Impact of bronchodilator responsiveness on quality of life and exercise capacity in patients with COPD","volume":"59","author":"Ortega","year":"2014","journal-title":"Respir Care"},{"key":"2026012203385436800_bib16","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1513\/AnnalsATS.201511-761OC","article-title":"Analysis of asthma-chronic obstructive pulmonary disease overlap syndrome defined on the basis of bronchodilator response and degree of emphysema","volume":"13","author":"Cosentino","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2026012203385436800_bib17","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","article-title":"Changes in forced expiratory volume in 1 second over time in COPD","volume":"365","author":"Vestbo","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012203385436800_bib18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1164\/ajrccm.159.4.9807121","article-title":"Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease","volume":"159","author":"Hansen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203385436800_bib19","first-page":"187","article-title":"Pathogenesis of hyperinflation in chronic obstructive pulmonary disease","volume":"9","author":"Gagnon","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203385436800_bib20","doi-asserted-by":"crossref","DOI":"10.3402\/ecrj.v1.25898","article-title":"Techniques of assessing small airways dysfunction","volume":"1","author":"McNulty","year":"2014","journal-title":"Eur Clin Respir J"},{"key":"2026012203385436800_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/15412550903499522","article-title":"Genetic epidemiology of COPD (COPDGene) study design","volume":"7","author":"Regan","year":"2010","journal-title":"COPD"},{"key":"2026012203385436800_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"2026012203385436800_bib23","doi-asserted-by":"crossref","first-page":"e000213","DOI":"10.1136\/bmjresp-2017-000213","article-title":"Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes","volume":"4","author":"Fortis","year":"2017","journal-title":"BMJ Open Respir Res"},{"key":"2026012203385436800_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","article-title":"Spirometric reference values from a sample of the general U.S. population","volume":"159","author":"Hankinson","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203385436800_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1183\/09031936.95.08030492","article-title":"Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements","volume":"8","author":"Stocks","year":"1995","journal-title":"Eur Respir J"},{"key":"2026012203385436800_bib26","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/nm.2971","article-title":"Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression","volume":"18","author":"Galb\u00e1n","year":"2012","journal-title":"Nat Med"},{"key":"2026012203385436800_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1164\/rccm.201511-2219OC","article-title":"Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease","volume":"194","author":"Bhatt","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203385436800_bib28","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1164\/rccm.201101-0021OC","article-title":"Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study","volume":"184","author":"Wan","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203385436800_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1513\/pats.200603-086MS","article-title":"State of the Art. A structural and functional assessment of the lung via multidetector-row computed tomography: phenotyping chronic obstructive pulmonary disease","volume":"3","author":"Hoffman","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"2026012203385436800_bib30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1164\/rccm.200801-059OC","article-title":"Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease","volume":"178","author":"Patel","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203385436800_bib31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12931-014-0102-5","article-title":"Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD","volume":"15","author":"Tashkin","year":"2014","journal-title":"Respir Res"},{"key":"2026012203385436800_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1465-9921-12-127","article-title":"The clinical features of the overlap between COPD and asthma","volume":"12","author":"Hardin","year":"2011","journal-title":"Respir Res"},{"key":"2026012203385436800_bib33","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1378\/chest.121.4.1042","article-title":"Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation","volume":"121","author":"Newton","year":"2002","journal-title":"Chest"},{"key":"2026012203385436800_bib34","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.chest.2016.12.017","article-title":"Bronchodilator response in FVC is larger and more relevant than in FEV1 in severe airflow obstruction","volume":"151","author":"Quanjer","year":"2017","journal-title":"Chest"},{"key":"2026012203385436800_bib35","first-page":"1191","article-title":"Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease","volume":"10","author":"Pisi","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203385436800_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1513\/pats.200508-093DO","article-title":"Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease","volume":"3","author":"O\u2019Donnell","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"2026012203385436800_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/15412550802092928","article-title":"The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease","volume":"5","author":"Walker","year":"2008","journal-title":"COPD"},{"key":"2026012203385436800_bib38","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.2147\/COPD.S111573","article-title":"Bronchodilator response of advanced lung function parameters depending on COPD severity","volume":"11","author":"Jarenb\u00e4ck","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026012203385436800_bib39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.pupt.2008.04.005","article-title":"The forgotten message from gold: FVC is a primary clinical outcome measure of bronchodilator reversibility in COPD","volume":"21","author":"Ben Saad","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"2026012203385436800_bib40","first-page":"91","article-title":"Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease","volume":"44","author":"Chhabra","year":"2002","journal-title":"Indian J Chest Dis Allied Sci"},{"key":"2026012203385436800_bib41","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1152\/jappl.2000.88.6.1989","article-title":"Mechanisms for isolated volume response to a bronchodilator in patients with COPD","volume":"88","author":"Cerveri","year":"2000","journal-title":"J Appl Physiol (1985)"},{"key":"2026012203385436800_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1186\/rr83","article-title":"Small airway inflammation in asthma","volume":"2","author":"Tulic","year":"2001","journal-title":"Respir Res"},{"key":"2026012203385436800_bib43","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12931-014-0084-3","article-title":"Airway wall thickness is increased in COPD patients with bronchodilator responsiveness","volume":"15","author":"Kim","year":"2014","journal-title":"Respir Res"},{"key":"2026012203385436800_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1183\/09059180.00002610","article-title":"Impact of exacerbations on COPD","volume":"19","author":"Anzueto","year":"2010","journal-title":"Eur Respir Rev"},{"key":"2026012203385436800_bib45","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.201209-1722OC","article-title":"Mortality by level of emphysema and airway wall thickness","volume":"187","author":"Johannessen","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203385436800_bib46","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1164\/rccm.201605-1014OC","article-title":"Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease","volume":"195","author":"Dransfield","year":"2017","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/7\/826\/66386070\/annalsats_16_7_826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/16\/7\/826\/66386070\/annalsats_16_7_826.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:42:32Z","timestamp":1769071352000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/16\/7\/826\/8423929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,7,1]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201809-601oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,7,1]]}}}